[Lead detoxication effect of a combined calcium phosphate and ascorbic acid therapy in pregnant women with increased lead burden (author's transl)].
In former papers it was stated that the fetus can be exposed a considerable burden by traces of heavy metals and that a combined therapy with calcium phosphate and ascorbic acid has a good detoxifying effect. In fourty lead-burdened mothers who were treated in this way the excretion of 5-aminolevulinic acid in urine decreased by 65%, the lead content of placenta by 90% and the lead content of mother's milk by 15% compared with a control group without treatment. The cadmium content of the placenta was reduced to 4% of the content in untreated mothers.
D000622:Aminolevulinic Acid / Q000652:urine; D001205:Ascorbic Acid / Q000627:therapeutic use*; D002104:Cadmium / Q000097:blood; D002105:Cadmium Poisoning / Q000188:drug therapy; D002130:Calcium Phosphates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007854:Lead / Q000097:blood; D007855:Lead Poisoning / Q000188:drug therapy*; D008431:Maternal-Fetal Exchange / Q000187:drug effects; D008895:Milk, Human / Q000378:metabolism; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D015032:Zinc / Q000097:blood
D002130:Calcium Phosphates; C485828:alpha-tricalcium phosphate; C485830:tetracalcium phosphate; D002104:Cadmium; D007854:Lead; C485838:calcium phosphate, monobasic, anhydrous; D000622:Aminolevulinic Acid; C020243:calcium phosphate; D015032:Zinc; C485829:calcium phosphate, dibasic, anhydrous; D001205:Ascorbic Acid
Uber die entbleiende Wirkung einer kombinierten Therapie mit Kalziumphosphat und Vitamin C bei erhöhter Bleibelastung in der Schwangerschaft. 10. Mitteilung über Schadstoff-Belastung und -Vorsorgeuntersuchungen.